Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-4,620 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-13,028 Reduced 73.82%
4,620 $81,000
Q2 2021

Aug 16, 2021

SELL
N/A
-1,625 Reduced 8.43%
17,648 $172,000
Q1 2021

May 13, 2021

BUY
N/A
4,580 Added 31.17%
19,273 $206,000
Q4 2020

Feb 09, 2021

BUY
N/A
725 Added 5.19%
14,693 $216,000
Q3 2020

Nov 05, 2020

BUY
N/A
8,968 Added 179.36%
13,968 $198,000
Q2 2020

Aug 13, 2020

BUY
N/A
1,700 Added 51.52%
5,000 $40,000
Q1 2020

May 14, 2020

BUY
N/A
3,300 New
3,300 $13,000

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.